The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery
RecruitingOBSERVATIONAL
Enrollment
40
Participants
Timeline
Start Date
February 1, 2025
Primary Completion Date
January 31, 2030
Study Completion Date
January 31, 2030
Conditions
Thyroid Cancer
Trial Locations (1)
200001
RECRUITING
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine, Shanghai
All Listed Sponsors
lead
Ruijin Hospital
OTHER
NCT06800768 - The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery | Biotech Hunter | Biotech Hunter